The City of Phoenix is pleased to announce the appointment of Ryan Touhill as the new Community and Economic Development Director.

Touhill brings nearly two decades of experience in local government and economic development, most recently serving as Director of Arlington Economic Development (AED) in Virginia. There, he led the creation and implementation of AED’s Strategic Plan for Economic Growth, positioning Arlington as a leader in the region’s tech and innovation ecosystem. Under his leadership, AED secured millions in new investment and supported the creation of thousands of jobs, while launching successful initiatives such as the All In Arlington tourism campaign and policies to revitalize commercial districts.Continue reading→

TUCSON, Ariz. — Tech Parks Arizona celebrates a powerful economic legacy, reporting a $2.6 billion annual economic impact. The figure comes from a newly released analysis of 2024 data, the organization’s milestone 30th anniversary year, and conducted by the independent research firm Rounds Consulting Group. Every five years, Tech Parks Arizona undertakes a comprehensive assessment of its three innovation hubs: the UA Tech Park at Rita Road, UA Tech Park at The Bridges and the University of Arizona Center for Innovation (UACI).  Continue reading→

You’ve worked hard to build great company. You want to shout it from the rooftops, but will the right audience hear you? AZBioPEERS – Getting the Word Out – Pitching the Media features a discussion with 3 highly experienced life science PR professionals and former journalists.  Watch the video to sit into their discussion.Continue reading→

AZBio Pioneer Award for Lifetime Achievement recognizes groundbreaking contributions in fight against Alzheimer’sContinue reading→

SCOTTSDALE, AZ, October 22, 2025 – CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced that it has been awarded a $3 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to determine if the presence of the protein phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) predicts the likelihood of developing Parkinson’s disease (PD). The company’s Syn-One Test^® will be studied as a predictive tool to help assess which patients may be at risk for developing PD. Outcomes from the “Syn-T Study” could have major implications for the treatment and management of people with ET in the future.Continue reading→

Collaboration delivers more than $59 billion in economic impact and statewide growth in patient care, research and opportunity.

Continue reading→

New York, USA – 24th October 2025 – GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully completed the acquisition of BacVax Inc. (“BacVax”), a biotechnology company based in Phoenix, Arizona, that is developing vaccines targeting bacterial infections.Continue reading→

College of Medicine – Phoenix’s Stewart Goldman and Vlad Kalinichenko have simple goal — make children’s lives better.
Continue reading→

Immediate, targeted radiation at the time of surgery reduces the risk of tumor recurrence or death by greater than 50% compared to standard of care in early clinical data readoutContinue reading→